FDA Inspection 1247057 — Matthew G. Davis, M.D.
The FDA completed an inspection of Matthew G. Davis, M.D. on August 9, 2024 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 9, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, NY (United States)
Additional Details
Clinical Investigator (CI)